Omnicell Stock Plunges As Short-Seller Accuses Medical Stock Of ‘Accounting Gimmicks’ Investor’s Business Daily
Omnicell stock tumbled Thursday after a short-seller accused the medical stock of “accounting gimmicks,” including prematurely recording revenue.